Hester Biosciences said that its board has approved the divestment of 43.81% equity shareholding in its subsidiary Texas Lifesciences (TLPL), by way of transfer/sale of shares to the existing promoter ...

TLPL is not material subsidiary of the Company. TLPL will ceased to be the subsidiary of the Company upon completion share transfer transaction as above.

MUMBAI, Sept 20 (Reuters) - Hester Biosciences Ltd has entered into a joint venture agreement with Nepal's Him Electronics to make animal vaccines in Nepal, the company said in a statement on Monday.